Interferon beta-1a (also interferon beta 1-alpha) is a cytokine in the interferon family used to treat multiple sclerosis (MS). It is produced by mammalian cells, while interferon beta-1b is produced in modified E. coli. Some research indicates that interferon injections may result in an 18–38% reduction in the rate of MS relapses.
Are you looking for or in search of FDA approved “interferon beta-1a for injection in India”? “Medicant Healthcare” a registered pharmacy firm in India deals in both brand name as well as generic name Drugs / medicine approved for multiple sclerosis. Need Access of interferon beta-1a for injection, get in touch with our healthcare professional.
![interferon beta-1a for injection price in Latin America, Russia, UK and USA. interferon beta-1a for injection price in Latin America, Russia, UK and USA.](https://medicanthealthcare.com/wp-content/uploads/2022/07/interferon-beta-1a-for-inje.jpg)
The earliest clinical presentation of relapsing-remitting multiple sclerosis is the clinically isolated syndrome (CIS), that is, a single attack of a single symptom. During a CIS, there is a subacute attack suggestive of demyelination which should be included in the spectrum of MS phenotypes. Treatment with interferons after an initial attack decreases the risk of developing clinical definite MS.
![private-investigator-2](https://medicanthealthcare.com/wp-content/uploads/2022/07/private-investigator-2.png)
interferon beta-1a for injection
Contact No.
Call us
+91 11 4350 7259
Emergency Contact
+91 93139 48015
Address
Visit us anytime
F-90/1 , Okhla Industrial Area,
Phase -1 , New Delhi. India
Send us an email
medicanthealthcare@outlook.com
info@medicanthealthcare.com